omistaviin
Omistaviin is a synthetic compound that has been developed as a potential treatment for various medical conditions, including cancer and neurodegenerative diseases. It is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4), which plays a crucial role in the breakdown of dipeptides, a type of peptide consisting of two amino acids.
The primary mechanism of action of omistaviin involves its ability to inhibit DPP-4, leading to an increase
In the context of cancer, omistaviin has been investigated for its potential to enhance the effectiveness of
Clinical trials are ongoing to evaluate the safety and efficacy of omistaviin in humans. Preliminary results
In summary, omistaviin is a novel compound with potential applications in the treatment of cancer and neurodegenerative